Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDX25 antisense RNA 1 (DDX25-AS1) is a long noncoding RNA (lncRNA) gene transcribed antisense to the protein-coding gene DEAD-box helicase 25 (DDX25)[1][6]. Antisense lncRNAs typically regulate the expression of their sense gene counterparts by various mechanisms, including modulation of RNA stability, epigenetic modifications, or formation of RNA duplexes, though the specific function of DDX25-AS1 in human biology is not yet characterized in detail[2][6]. No scientific data currently identify DDX25-AS1 itself as a direct therapeutic target, nor are there drugs documented to act on this molecule. The full spectrum of its roles, interacting molecules, and therapeutic relevance remain to be determined. Note: - Information on DDX25-AS1 itself is limited; DDX25, the sense gene, is a well-characterized ATP-dependent RNA helicase involved in spermatogenesis, but this should not be confused with DDX25-AS1, which is a noncoding RNA transcribed from the opposite strand[3][5][7]. - No major errors or misspellings were found for this gene symbol and name, and it matches entries in authoritative gene databases[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDX25 antisense RNA 1 (DDX25-AS1).